Roivant Sciences (ROIV) Treasury Shares (2021 - 2025)
Roivant Sciences (ROIV) posted Treasury Shares of $348527.0 for Q1 2025, down 50.92% on a QoQ basis from $710060.0 in Q4 2024, and down 96.93% year-over-year from $11.4 million in Q1 2024.
Roivant Sciences (ROIV) Treasury Shares (2021 - 2025) Analysis & Trends
Roivant Sciences' Treasury Shares history runs 5 years deep, the most recent figure standing at $348527.0 for Q1 2025.
- Quarterly Treasury Shares fell 96.93% year-over-year to $348527.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $348527.0 (down 96.93% YoY) and the FY2025 annual result came in at $348527.0, down 96.93% from the prior year.
- Treasury Shares was $348527.0 for Q1 2025 at Roivant Sciences, down from $710060.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $52.0 million in Q3 2024 and bottomed at $348527.0 in Q1 2025.
- A 5-year average of $15.8 million and a median of $17.0 million in 2024 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2024 — Treasury Shares soared 525.51% — and 2025, when it sank 96.93%.
- Roivant Sciences' Treasury Shares stood at $22.6 million in 2021, then retreated by 1.92% to $22.2 million in 2022, then slumped by 90.35% to $2.1 million in 2023, then slumped by 66.8% to $710060.0 in 2024, then plunged by 50.92% to $348527.0 in 2025.
- Business Quant data shows ROIV's Treasury Shares at $348527.0 in Q1 2025, $710060.0 in Q4 2024, and $52.0 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Roivant Sciences | 24.35 Bn | 25.12 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 348,527.00 |
| Mar 31, 2025 | 348,527.00 |
| Dec 31, 2024 | 710,060.00 |
| Dec 31, 2024 | 710,060.00 |
| Sep 30, 2024 | 52.01 Mn |
| Sep 30, 2024 | 52.01 Mn |
| Jun 30, 2024 | 16.98 Mn |
| Jun 30, 2024 | 16.98 Mn |
| Mar 31, 2024 | 11.36 Mn |
| Mar 31, 2024 | 11.36 Mn |
| Dec 31, 2023 | 2.14 Mn |
| Dec 31, 2023 | 2.14 Mn |
| Sep 30, 2023 | 20.07 Mn |
| Sep 30, 2023 | 20.07 Mn |
| Jun 30, 2023 | 21.42 Mn |
| Jun 30, 2023 | 21.42 Mn |
| Mar 31, 2023 | 1.82 Mn |
| Mar 31, 2023 | 1.82 Mn |
| Dec 31, 2022 | 22.15 Mn |
| Dec 31, 2022 | 22.15 Mn |